Joint Filing AgreementJoint Filing Agreement • October 23rd, 2019 • Engine Capital, L.P. • Biological products, (no disgnostic substances)
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including amendments thereto) with respect the shares of common stock, par value $0.01 per share, of PDL BioPharma, Inc., a Delaware Corporation. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
